Literature DB >> 17127451

Mitochondrial contribution to the molecular mechanism of heart acclimatization to chronic hypoxia: role of nitric oxide.

Tamara Zaobornyj1, Gustavo F Gonzales, Laura B Valdez.   

Abstract

A remarkable number of adaptive responses; including changes in the cardiovascular, respiratory and hematologic systems; takes place during acclimatization to natural or simulated high altitude. This adaptation to chronic hypoxia confers the heart an improved tolerance to all major deleterious consequences of acute O2 deprivation, not only reducing infarct size but also alleviating post-ischemic contractile dysfunction and ventricular arrhythmias. There is growing evidence about the involvement of mitochondria and NO in the establishment of cardioprotection. This review focuses on evidence about the putative role of different effectors of heart acclimatization to chronic hypoxia. Along with classical parameters, we consider NO, specially that generated by mtNOS, mitochondrial respiratory chain, mitoK(ATP) channels, reactive oxygen species and control of gene expression by HIF-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17127451     DOI: 10.2741/2143

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  4 in total

Review 1.  Cardiac metabolic adaptations in response to chronic hypoxia.

Authors:  M Faadiel Essop
Journal:  J Physiol       Date:  2007-08-30       Impact factor: 5.182

2.  Sustained hypoxia modulates mitochondrial DNA content in the neonatal rat brain.

Authors:  Heung M Lee; George H Greeley; Ella W Englander
Journal:  Free Radic Biol Med       Date:  2007-11-21       Impact factor: 7.376

3.  Characteristics and function of cardiac mitochondrial nitric oxide synthase.

Authors:  Elena N Dedkova; Lothar A Blatter
Journal:  J Physiol       Date:  2008-12-22       Impact factor: 5.182

4.  The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia.

Authors:  Lothar A Schwarte; Ingo Schwartges; Kai Thomas; Patrick Schober; Olaf Picker
Journal:  Intensive Care Med       Date:  2011-03-05       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.